---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-036320"
form_type: "8-K"
ticker: "TRDA"
cik: "0001689375"
company_name: "Entrada Therapeutics, Inc."
filed_at: "2022-03-22T23:59:59+00:00"
generated_at: "2026-06-26T21:02:09.653812+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Entrada Therapeutics signs 10-year lease for ~81,442 sq ft HQ in Boston

## Summary
- Lease for fifth and sixth floors of One Design Center Place, Boston; 10-year term with 5-year renewal option.
- Initial base rent ~$525,417/month for first 12 months (based on 65,000 sq ft), then 3% annual increases for full 81,442 sq ft.
- Landlord provides up to ~$19.5M tenant improvement allowance ($240/sq ft) and additional ~$1.63M contribution repayable over 10 years at 8% interest.
- Rent commencement is earlier of occupancy or 10 months after delivery; expected delivery around April 1, 2022.
- Security deposit of ~$3.95M in letter of credit; Landlord's Work includes pre- and post-delivery improvements.

## SEC filing metadata
- accession: 0001104659-22-036320
- form_type: 8-K
- ticker: TRDA
- cik: 0001689375
- company_name: Entrada Therapeutics, Inc.
- filed_at: 2022-03-22T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 2.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1689375/000110465922036320/0001104659-22-036320-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1689375/000110465922036320/tm228415d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-036320
- JSON: https://secwatch.observer/filing/0001104659-22-036320.json
- Plain text: https://secwatch.observer/filing/0001104659-22-036320.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.